4.8 Review

CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

Sharon H. Giordano et al.

Summary: ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations in response to new and practice-changing data, aiming to disseminate updated recommendations in a timely manner to inform health practitioners and the public on the best available cancer care options.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

Si-Wei Wang et al.

Summary: The CRISPR/Cas9 gene editing technology has made significant progress in oncological research, providing a powerful tool for exploring the mechanism of cancer, establishing tumor models, and studying drug targets.

MOLECULAR CANCER (2022)

Article Chemistry, Multidisciplinary

Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity

Wencheng Wu et al.

Summary: This study reports a novel microbiotic nanomedicine LOD/TPZ@Lips-LA, which combines lactate oxidase (LOD) and prodrug tirapazamine (TPZ) loaded liposomes anchored on lactobacillus (LA) surface for chemotherapy-synergized antitumor immunity. The nanomedicine induces tumor cell apoptosis through in situ ROS generation and TPZ activation based on LA metabolism, resulting in strong immunogenic cell death (ICD). By regulating biomarker expression, it promotes anti-tumorigenic M1 polarization of innate tumor-associated macrophages and infiltration of adaptive cytotoxic CD8+ T cells, synergistically enhancing the tumor inhibition effects.

NANO TODAY (2022)

Article Nanoscience & Nanotechnology

Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy

Di Zhang et al.

Summary: Modulating the mechanical properties of tumor cells enhances gene editing and inhibits tumor growth by using dendrimer lipid nanoparticles for PD-L1 gene editing and knocking out FAK.

NATURE NANOTECHNOLOGY (2022)

Article Engineering, Biomedical

A Cancer Cell Membrane-Derived Biomimetic Nanocarrier for Synergistic Photothermal/Gene Therapy by Efficient Delivery of CRISPR/Cas9 and Gold Nanorods

Lin Huang et al.

Summary: A cancer cell membrane-derived nanocarrier was developed for synergistic photothermal/gene therapy. This nanotherapeutic platform showed high biocompatibility, homologous targeting capacity, and efficient payload delivery, leading to enhanced therapeutic efficacy.

ADVANCED HEALTHCARE MATERIALS (2022)

Letter Biochemistry & Molecular Biology

A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders

Xiaojie Xu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Sonodynamic therapy-derived multimodal synergistic cancer therapy

Mimi Xu et al.

Summary: Sonodynamic therapy (SDT) offers a promising approach for non-invasively eliminating solid tumors, and combining it with other therapeutic methods can enhance tumor treatment effects. The potential of SDT-based synergistic therapeutics is highlighted for precision tumor treatment medicine.

CANCER LETTERS (2021)

Article Oncology

Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway

Nathan Harmston et al.

Summary: Aberrant Wnt signaling in cancer drives both widespread gene repression and activation, promoting cancer cell proliferation. Inhibiting Wnt signaling leads to increased gene expression through activation of the ERK and JNK pathways.

CANCER RESEARCH (2021)

Review Chemistry, Inorganic & Nuclear

Oxygen self-sufficient photodynamic therapy

Fangmian Wei et al.

Summary: Photodynamic therapy is a non-invasive treatment for cancers and non-malignant diseases, but some agents are limited by their oxygen-dependent nature in hypoxic solid tumors. Recent advances in oxygen self-sufficient nanomaterials offer opportunities to overcome this challenge and improve the efficacy of PDT in hypoxia.

COORDINATION CHEMISTRY REVIEWS (2021)

Article Chemistry, Multidisciplinary

Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy

Xiangyu Deng et al.

Summary: Phototherapy, such as photothermal therapy and photodynamic therapy, has shown great potential in cancer treatment, but there are still many challenges that need to be addressed. Scientists are designing different systems to overcome the drawbacks associated with phototherapy, aiming to make it a more effective cancer treatment approach in clinical practice. This article discusses the problems and solutions in phototherapy research, providing insights for future advancements in the field.

ADVANCED SCIENCE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Chemistry, Multidisciplinary

A Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy

Tao Wan et al.

Summary: This study developed a CRISPR-Cas9-based genome-editing nanomedicine that targets both APC and KRAS mutations in human colorectal cancer. Systemic administration of Cas9 RNP enabled by HAPD significantly inhibited tumor growth in mouse models and prevented CRC-induced liver and lung metastasis. This duplex genome-editing system provides a promising gene therapy strategy for human CRC and potentially other cancers with similar genetic mutations.

NANO LETTERS (2021)

Article Chemistry, Multidisciplinary

Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma

Haohao Yin et al.

Summary: This study identified the activation of NFE2L2 during SDT, which hindered the treatment efficacy. A novel HMME @ Lip-Cas9 system was designed to enhance therapeutic efficiency, laying the groundwork for new approaches in HCC management.

ACS CENTRAL SCIENCE (2021)

Review Chemistry, Multidisciplinary

Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy

Haitao Sun et al.

Summary: Cancer nanomedicines offer promising treatment strategies, with photothermal therapy identified as a safe modality for achieving photothermal synergistic cancer therapy and significantly improved benefits.

NANO TODAY (2021)

Article Chemistry, Multidisciplinary

Programmable Unlocking Nano-Matryoshka-CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response

Jin Yang et al.

Summary: The PUN system targets PD-L1 and PTPN2 for permanent, complete and highly responsive immunotherapy. By releasing CRISPR/Cas9 to efficiently disrupt PD-L1 and PTPN2 in tumor cells, it enhances adaptive immune responses.

ADVANCED SCIENCE (2021)

Review Pharmacology & Pharmacy

Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment q

Xiaoyu Xu et al.

Summary: CRISPR/Cas9 is a potent gene-editing technology that shows promise for cancer therapy, but faces challenges in clinical applications. Nanotechnology plays a significant role in cancer drug delivery, aiding in overcoming the barriers of in vivo delivery for CRISPR/Cas9.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Chemistry, Multidisciplinary

CRISPR/Cas9-2D Silicene Gene-Editing Nanosystem for Remote NIR-II-Induced Tumor Microenvironment Reprogramming and Augmented Photonic Tumor Ablation

Haohao Yin et al.

Summary: This study successfully addressed the issue of reduced efficacy in photothermal ablation due to upregulation of TXNDC5 gene expression following PTT by constructing a NIR-II light-controlled CRISPR/Cas9 nanosystem based on silicene. The system enabled remote reprogramming of the tumor microenvironment, enhancing photonic tumor ablation effect and significantly improving gene editing efficiency. This approach not only offers a solution to the challenges in photothermal tumor therapy, but also demonstrates the wide biomedical application potential of 2D silicene nanosheets.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Chemistry, Multidisciplinary

Sono-Controllable and ROS-Sensitive CRISPR-Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy

Yinying Pu et al.

Summary: A sono-controllable and ROS-sensitive nanomedicine, P/M@CasMTH1, has been developed for enhanced sonodynamic therapy by disrupting MTH1 gene in tumor cells, leading to cellular apoptosis and tumor suppression.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Hypoxia-Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild-Photothermal Therapy

Xueqing Li et al.

Summary: This study develops a hypoxia-responsive nanocomposite for mild-photothermal therapy through gene editing in tumors. The technology has the potential to enhance tumor ablation efficiency and reduce damage to surrounding healthy tissues.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Multidisciplinary

Controlled CRISPR-Cas9 Ribonucleoprotein Delivery for Sensitized Photothermal Therapy

Chao Chen et al.

Summary: A near-infrared light-triggered thermo-responsive copper sulfide multifunctional nanotherapeutic platform was developed for controlled release of CRISPR-Cas9 ribonucleoprotein and doxorubicin, showing potential for synergistic combination therapy in cancer treatment.
Article Chemistry, Multidisciplinary

Reduction-Sensitive Fluorinated-Pt(IV) Universal Transfection Nanoplatform Facilitating CT45-Targeted CRISPR/dCas9 Activation for Synergistic and Individualized Treatment of Ovarian Cancer

Hongtong Lu et al.

Summary: A PtUTP-F nanoplatform was developed for targeted CRISPR/dCas9 activation of CT45, achieving synergistic and individualized treatment. PtUTP-F can efficiently transfect different cells and enhance sensitivity to Pt(II) drugs, serving as a novel strategy for treatment.
Article Multidisciplinary Sciences

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

Lauren Giuffrida et al.

Summary: The study showed that targeting the A(2A)R gene using CRISPR/Cas9 significantly enhances the efficacy of CAR T cells, leading to improved survival rates in mice and potential for enhanced tumor control.

NATURE COMMUNICATIONS (2021)

Review Chemistry, Multidisciplinary

Advanced biotechnology-assisted precise sonodynamic therapy

Yi Zhang et al.

Summary: The article discusses the advantages and potential of photodynamic therapy and sonodynamic therapy in the treatment of deep-seated tumors, as well as imaging-guided precise SDT and recent clinical trials. It also summarizes the strategies for designing sonosensitizers based on tumor environment and structure modifications, as well as the approach of SDT combination therapy.

CHEMICAL SOCIETY REVIEWS (2021)

Review Biochemistry & Molecular Biology

Spatiotemporal control of CRISPR/Cas9 gene editing

Chenya Zhuo et al.

Summary: The CRISPR/Cas9 gene editing technology shows promise in treating genetic and infectious diseases but faces challenges in precise editing. Emerging strategies to regulate CRISPR/Cas9 activity have shown potential in improving spatiotemporal control, but obstacles and limitations remain for clinical translation. Further exploration is needed to enhance the spatiotemporal operability of CRISPR/Cas9.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Chemistry, Physical

Chain-shattering Pt(IV)-backboned polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic cancer therapy

Qingfei Zhang et al.

Summary: A chain-shattering Pt(IV)-backboned polymeric nanoplatform has been developed for the targeted delivery of EZH2-targeted CRISPR/Cas9 system in prostate cancer treatment, achieving efficient EZH2 gene disruption and significant downregulation of EZH2 protein expression. The system also led to enhanced apoptosis through H3K27me3 downregulation, resulting in substantial inhibition of prostate cancer cell proliferation and growth repression of subcutaneous xenograft tumors. This innovative nanoplatform not only provides a prospective nanocarrier for CRISPR/Cas9 system delivery, but also broadens the potential of combining gene editing-chemo synergistic cancer therapy.

NANO RESEARCH (2021)

Article Medicine, Research & Experimental

A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer

Chao Liu et al.

Summary: The study presented a novel nanoCRISPR, named PICASSO, that efficiently activates tumor endogenous genes for effective anti-tumor therapy. By targeting endogenous genes in tumor cells, the therapy can inhibit tumor growth effectively, overcoming the limitations of gene size and type.

THERANOSTICS (2021)

Review Chemistry, Multidisciplinary

Two-Dimensional Nanomaterials for Photothermal Therapy

Shuang Liu et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Review Multidisciplinary Sciences

The promise and challenge of therapeutic genome editing

Jennifer A. Doudna

NATURE (2020)

Article Multidisciplinary Sciences

Genomic basis for RNA alterations in cancer

Claudia Calabrese et al.

NATURE (2020)

Article Multidisciplinary Sciences

The evolutionary history of 2,658 cancers

Moritz Gerstung et al.

NATURE (2020)

Article Multidisciplinary Sciences

Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing

Xiaohong Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Oncology

Cancer burden of major cancers in China: A need for sustainable actions

Maomao Cao et al.

CANCER COMMUNICATIONS (2020)

Review Chemistry, Multidisciplinary

Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy

Shuang Liang et al.

ADVANCED MATERIALS (2020)

Review Chemistry, Multidisciplinary

Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system

Hossein Rahimi et al.

NANO TODAY (2020)

Review Oncology

Targeting the Wnt/β-catenin signaling pathway in cancer

Ya Zhang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Oncology

A compendium of mutational cancer driver genes

Francisco Martinez-Jimenez et al.

NATURE REVIEWS CANCER (2020)

Article Medicine, General & Internal

Radiotherapy toxicity

Dirk De Ruysscher et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Article Multidisciplinary Sciences

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

Fiona M. Behan et al.

NATURE (2019)

Review Nanoscience & Nanotechnology

Cancer nanomedicine for combination cancer immunotherapy

Jutaek Nam et al.

NATURE REVIEWS MATERIALS (2019)

Review Oncology

Current Landscape of Immunotherapy in Breast Cancer: A Review

Sylvia Adams et al.

JAMA ONCOLOGY (2019)

Review Cell Biology

Immunogenic cell death in cancer therapy: Present and emerging inducers

Jingyi Zhou et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Chemistry, Multidisciplinary

Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition

Wencheng Wu et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)

Editorial Material Oncology

The Sly Oncogene: FOXA1 Mutations in Prostate Cancer

Neel Shah et al.

CANCER CELL (2019)

Editorial Material Multidisciplinary Sciences

A dynamic view of chemotherapy

Yunpeng Liu et al.

NATURE (2019)

Article Multidisciplinary Sciences

Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel

Peng Guo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Biochemistry & Molecular Biology

Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer

Tala M. Abu Samaan et al.

BIOMOLECULES (2019)

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Chemistry, Multidisciplinary

Glucose Oxidase-Instructed Multimodal Synergistic Cancer Therapy

Lian-Hua Fu et al.

ADVANCED MATERIALS (2019)

Review Oncology

Tumour heterogeneity and resistance to cancer therapies

Ibiayi Dagogo-Jack et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Medicine, Research & Experimental

Photodynamic therapy - mechanisms, photosensitizers and combinations

Stanislaw Kwiatkowski et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Chemistry, Multidisciplinary

Organic molecule-based photothermal agents: an expanding photothermal therapy universe

Hyo Sung Jung et al.

CHEMICAL SOCIETY REVIEWS (2018)

Editorial Material Oncology

IMMUNOTHERAPY Cancer immunotherapy and the value of cure

Joseph C. Del Paggio

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Letter Oncology

Paclitaxel and Pazopanib in Ovarian Cancer

Federica Tomao et al.

JAMA ONCOLOGY (2018)

Review Multidisciplinary Sciences

CRISPR-Cas guides the future of genetic engineering

Gavin J. Knott et al.

SCIENCE (2018)

Review Biochemistry & Molecular Biology

Modulating DNA Repair Pathways to Improve Precision Genome Engineering

Katherine S. Pawelczak et al.

ACS CHEMICAL BIOLOGY (2018)

Article Chemistry, Multidisciplinary

Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice

Ling Li et al.

ACS NANO (2017)

Review Oncology

Type II CRISPR/Cas9 approach in the oncological therapy

A. Biagioni et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Article Multidisciplinary Sciences

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

Justin Eyquem et al.

NATURE (2017)

Editorial Material Engineering, Biomedical

Nanoparticles for CRISPR-Cas9 delivery

Zachary Glass et al.

NATURE BIOMEDICAL ENGINEERING (2017)

Review Chemistry, Multidisciplinary

Nanotechnology for Multimodal Synergistic Cancer Therapy

Wenpei Fan et al.

CHEMICAL REVIEWS (2017)

Review Chemistry, Multidisciplinary

Photodynamic Therapy: Past, Present and Future

Ushasri Chilakamarthi et al.

CHEMICAL RECORD (2017)

Article Oncology

Mutational Signatures in Breast Cancer: The Problem at the DNA Level

Serena Nik-Zainal et al.

CLINICAL CANCER RESEARCH (2017)

Review Cell Biology

Cancer immunotherapies targeting the PD-1 signaling pathway

Yoshiko Iwai et al.

JOURNAL OF BIOMEDICAL SCIENCE (2017)

Review Cell Biology

Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation

Antonia A. Dominguez et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Article Multidisciplinary Sciences

Rationally engineered Cas9 nucleases with improved specificity

Ian M. Slaymaker et al.

SCIENCE (2016)

Review Chemistry, Multidisciplinary

Micro/Nanoparticle-Augmented Sonodynamic Therapy (SDT): Breaking the Depth Shallow of Photoactivation

Xiaoqin Qian et al.

ADVANCED MATERIALS (2016)

Article Multidisciplinary Sciences

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

Keiichiro Suzuki et al.

NATURE (2016)

Article Multidisciplinary Sciences

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

R. Dixon Dorand et al.

SCIENCE (2016)

Article Medicine, Research & Experimental

HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy

Tzu-yin Lin et al.

THERANOSTICS (2016)

Review Microbiology

CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems

Wenyan Jiang et al.

ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)

Article Genetics & Heredity

CRISPR-Cas9: a new and promising player in gene therapy

Lu Xiao-Jie et al.

JOURNAL OF MEDICAL GENETICS (2015)

Review Multidisciplinary Sciences

Gene therapy returns to centre stage

Luigi Naldini

NATURE (2015)

Article Biotechnology & Applied Microbiology

Inducible in vivo genome editing with CRISPR-Cas9

Lukas E. Dow et al.

NATURE BIOTECHNOLOGY (2015)

Article Biotechnology & Applied Microbiology

Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

Junwei Shi et al.

NATURE BIOTECHNOLOGY (2015)

Article Cell Biology

Personalized genomic analyses for cancer mutation discovery and interpretation

Sian Jones et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Review Biochemistry & Molecular Biology

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway

Kim C. Ohaegbulam et al.

TRENDS IN MOLECULAR MEDICINE (2015)

Article Oncology

Immune Escape Mechanisms as a Guide for Cancer Immunotherapy

Gregory L. Beatty et al.

CLINICAL CANCER RESEARCH (2015)

Article Oncology

Applications of the CRISPR-Cas9 system in cancer biology

Francisco J. Sanchez-Rivera et al.

NATURE REVIEWS CANCER (2015)

Article Biochemistry & Molecular Biology

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Luke A. Gilbert et al.

Review Biochemistry & Molecular Biology

Development and Applications of CRISPR-Cas9 for Genome Engineering

Patrick D. Hsu et al.

Review Biochemistry & Molecular Biology

Cellular Levels of 8-Oxoguanine in either DNA or the Nucleotide Pool Play Pivotal Roles in Carcinogenesis and Survival of Cancer Cells

Yusaku Nakabeppu

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Review Genetics & Heredity

Non-viral vectors for gene-based therapy

Hao Yin et al.

NATURE REVIEWS GENETICS (2014)

Review Microbiology

Unravelling the structural and mechanistic basis of CRISPR-Cas systems

John van der Oost et al.

NATURE REVIEWS MICROBIOLOGY (2014)

Article Biochemistry & Molecular Biology

Classification and evolution of type II CRISPR-Cas systems

Krzysztof Chylinski et al.

NUCLEIC ACIDS RESEARCH (2014)

Review Pharmacology & Pharmacy

Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors

Todd M. Pitts et al.

PHARMACOLOGY & THERAPEUTICS (2014)

Review Multidisciplinary Sciences

The new frontier of genome engineering with CRISPR-Cas9

Jennifer A. Doudna et al.

SCIENCE (2014)

Review Oncology

Regulation and Role of EZH2 in Cancer

Hirohito Yamaguchi et al.

CANCER RESEARCH AND TREATMENT (2014)

Review Biochemistry & Molecular Biology

Lessons from the Cancer Genome

Levi A. Garraway et al.

Review Chemistry, Multidisciplinary

Recent advances in delivery of drug-nucleic acid combinations for cancer treatment

Jing Li et al.

JOURNAL OF CONTROLLED RELEASE (2013)

Review Cell Biology

INNOVATION TALENs: a widely applicable technology for targeted genome editing

J. Keith Joung et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)

Article Multidisciplinary Sciences

Multiplex Genome Engineering Using CRISPR/Cas Systems

Le Cong et al.

SCIENCE (2013)

Review Oncology

Cancer drug resistance: an evolving paradigm

Caitriona Holohan et al.

NATURE REVIEWS CANCER (2013)

Article Multidisciplinary Sciences

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

Giedrius Gasiunas et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Multidisciplinary Sciences

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Martin Jinek et al.

SCIENCE (2012)

Review Oncology

Programmed cell removal: a new obstacle in the road to developing cancer

Mark P. Chao et al.

NATURE REVIEWS CANCER (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Multidisciplinary Sciences

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

Gina M. De Nicola et al.

NATURE (2011)

Article Multidisciplinary Sciences

Multistage nanoparticle delivery system for deep penetration into tumor tissue

Cliff Wong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Multidisciplinary Sciences

Targeted Genome Editing Across Species Using ZFNs and TALENs

Andrew J. Wood et al.

SCIENCE (2011)

Article Multidisciplinary Sciences

Self versus non-self discrimination during CRISPR RNA-directed immunity

Luciano A. Marraffini et al.

NATURE (2010)

Review Genetics & Heredity

Genome editing with engineered zinc finger nucleases

Fyodor D. Urnov et al.

NATURE REVIEWS GENETICS (2010)

Article Biochemistry & Molecular Biology

A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination

Dong-Hyun Lee et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)

Review Medicine, General & Internal

Triple-Negative Breast Cancer

William D. Foulkes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Multidisciplinary Sciences

CRISPR/Cas, the Immune System of Bacteria and Archaea

Philippe Horvath et al.

SCIENCE (2010)

Review Oncology

Targeting the dynamic HSP90 complex in cancer

Jane Trepel et al.

NATURE REVIEWS CANCER (2010)

Review Biotechnology & Applied Microbiology

Cell cycle kinases as therapeutic targets for cancer

Silvia Lapenna et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Medicine, Research & Experimental

EPIGENETIC CHANGES IN TUMOR SUPPRESSOR GENES, P15, P16, APC-3 AND E-CADHERIN IN BODY FLUID

Mei-Ling Chen et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2007)

Review Biochemistry & Molecular Biology

Wnt/β-catenin signaling in development and disease

Hans Clevers

Review Oncology

HSP90 and the chaperoning of cancer

L Whitesell et al.

NATURE REVIEWS CANCER (2005)

Article Materials Science, Multidisciplinary

Targeted cancer nanotherapy

Gloria J. Kim et al.

MATERIALS TODAY (2005)

Article Oncology

Timeline - Chemotherapy and the war on cancer

BA Chabner et al.

NATURE REVIEWS CANCER (2005)

Article Multidisciplinary Sciences

The polycomb group protein EZH2 is involved in progression of prostate cancer

S Varambally et al.

NATURE (2002)